As we turn the page to 2024, the promises a new year holds begin to take shape in our minds. Our aspirations for the coming year are crystallizing, and for women, how to best nurture our health and well-being is the biggest item on the list for many.
In pursuing a lifestyle that champions healthy aging and longevity, embracing diets or temporary trends is sure to leave us back where we started. For women whose health is closely linked to hormonal changes, the need for increased knowledge is critical.
MenaQ7® K2: The Key to Women's Healthy Living
A woman’s well-being is intricately linked to the robustness of bone and cardiovascular health—two pivotal aspects not to be overlooked in pursuing a sustainable longevity strategy.
Up to 90 percent of peak bone mass is acquired by age 18 in girls, which means that for teenage girls and young women, a focus on bone health and bone building should be top of mind. When we hit 30, peak bone mass is attained, and from there on out, it is all about maintaining our bone mass as we go through pregnancy, nursing, and later menopause.
While cardiovascular disease has long been perceived as a “man’s disease,” it remains a significant threat to women’s health, especially with the hormonal shift they experience in their post-childbearing years. Shockingly, Lancet reports that 275 million women were diagnosed with cardiovascular disease in 2019.
MenaQ7®: The Proven K2 for Women's Bone and Cardiovascular Health
Lancet also reports that women are “underrepresented” in cardiovascular clinical studies. To that end, we take pride that MenaQ7® carries clinical validation for supporting bone and heart health in studies of healthy post-menopausal women. These are two core elements that empower women to flourish and age gracefully.
- Our three-year clinical trial published in Osteoporosis International showed that daily supplementation of MenaQ7® improved bone strength and supported the maintenance of bone mineral content and bone mineral density compared to placebo.
- Our findings published in Thrombosis and Haemostasis showed MenaQ7® inhibited age-related stiffening of the artery walls while also leading to a statistically significant improvement in vascular elasticity.
- Our latest findings, presented at the esteemed European Society of Cardiology Congress in August 2023, confirm that hormonal changes affect the vasculature and that post-menopausal women suffer from increased vascular stiffness. The study highlights that improved K2 status improves arterial stiffness and blood pressure in post-menopausal women.
Proven Efficacy for Women's Health
While increasing our weekly exercise regimen, focusing on mobility and weight training, is essential for women, incorporating a daily supplement of MenaQ7® is a proven and affordable insurance for female health and should be included by all women.
Make sure your next product development for women’s healthy aging features the K2 that brings proven claims to your brand: MenaQ7®.